MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejca.2016.01.019

Медицинская библиотека · European journal of cancer (Oxford, England : 1990) · 2016

Survival impact and predictive factors of axillary recurrence after sentinel biopsy.

Houvenaeghel Gilles, Classe Jean Marc, Garbay Jean-Rémy, Giard Sylvie, Cohen Monique, Faure Chistine, Charytansky Hélène, Rouzier Roman, Daraï Emile, Hudry Delphine, Azuar Pierre, Villet Richard, Gimbergues Pierre, Tunon de Lara Christine, Martino Marc, Fraisse Jean, Dravet François, Chauvet Marie Pierre, Goncalves Anthony, Lambaudie Eric

Сравнительное исследованиеСтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

The rate of axillary recurrence (AR) after sentinel lymph node biopsy is usually low but few studies investigated its impact on survival. Our aim was to determine the rate and predictive factors of AR in a large cohort of breast cancer patients and its impact on survival.

PATIENTS AND

METHODS

From 1999 to 2013, 14,095 patients who underwent surgery for clinically N0 previously untreated breast cancer and had sentinel lymph node biopsy were analysed. A simplified score predictive of AR was established.

RESULTS

Median follow-up was 55.2 months. AR was observed in 0.51% of cases, with a median time to onset of 43.4 months. In multivariate analysis, the occurrence of AR was significantly correlated with grade 2 or 3 disease, absence of radiotherapy and tumour subtype (hormonal receptor [HR]- / human estrogen receptor [HER]+). AR rates were 1% for triple-negative tumours, 2.8% for HER2-positive tumours, 0.4% for luminal A tumours, 0.9% for HER2-negative luminal B tumours, and 0.5% for HER2-positive luminal B tumours. A simplified score predictive of the occurrence of AR was established. Patients could be divided into three different score groups (p < 0.0001). In multivariate analysis, overall survival was significantly lower in cases of AR (p < 0.0001), age >50, lymphovascular invasion, grade 3 disease, sentinel node (SN) macrometastases, tumour size >20 mm, absence of chemotherapy and triple-negative phenotype. Survival in patients with AR was significantly lower in case of early-onset (2 years) AR (p = 0.017).

CONCLUSIONS

Isolated AR is more common in Her2-positive/HR-negative triple-negative tumours with a more severe prognosis in triple-negative and Her2-positive/HR-negative tumours, and represents an independent adverse factor justifying an indication for systemic treatment for AR treatment. However, the benefit of any systemic treatment remains to be proven.

Для цитирования: Houvenaeghel Gilles, Classe Jean Marc, Garbay Jean-Rémy, Giard Sylvie, Cohen Monique, Faure Chistine, Charytansky Hélène, Rouzier Roman, Daraï Emile, Hudry Delphine, Azuar Pierre, Villet Richard, Gimbergues Pierre, Tunon de Lara Christine, Martino Marc, Fraisse Jean, Dravet François, Chauvet Marie Pierre, Goncalves Anthony, Lambaudie Eric. Survival impact and predictive factors of axillary recurrence after sentinel biopsy.. European journal of cancer (Oxford, England : 1990). 2016. DOI: 10.1016/j.ejca.2016.01.019.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.